Joint Venture Investment Agreement of Harbin Tian Xin Biological Engineering Co., Ltd.Joint Venture Investment Agreement • December 16th, 2011 • China Sky One Medical, Inc. • Pharmaceutical preparations
Party A is specialized in stem cell clinical application technology with rich stem cell technology resources, human resources and advanced lab equipments. Party B is a pharmaceutical technology enterprise with extensive experience of stem cell technology development and enterprise management, market development ability and solid capital support. Party C is a comprehensive investment company with solid capital support. Party D is representative of several individual investors with cash investments. The four Parties agree to establish Harbin Tian Xin Biological Engineering Co., Ltd. as a joint venture (herein after referred as “Joint Venture”).
